Mind Medicine
在场
高管
查看带有其 24 名主要高管的组织结构图
Mind Medicine 搜索最多的简介
高管在Mind Medicine变化
- Javier Muniz已作为Vice President, Research and Development Strategy加入公司 (新闻发布的2024十二月3号).
- Gregg Pratt已作为Chief Regulatory Affairs and Quality Assurance Officer加入公司 (新闻发布的2024十一月19号).
- Stephanie Fagan已作为Chief Corporate Affairs Officer加入公司 (新闻发布的2024七月30号).
创建提醒
跟踪 Mind Medicine 的高管变动
生物技术
Mind Medicine 拥有 2,332 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
- Hopo Therapeutics 刚刚宣布为 226 筹款数百万美元。 (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
Mind Medicine 的最新新闻稿
- MindMed Reports Third Quarter 2023 Financial Results and Business Highlights - MindMed
- MindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD) - MindMed
- MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business Update - MindMed
- MindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) Congress - MindMed
- MindMed Completes Enrollment of Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD) - MindMed
- MindMed to Participate in the TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit - MindMed
- MindMed to Participate at September Investor Conferences - MindMed
- MindMed Secures $50.0 Million Credit Facility with K2 HealthVentures - MindMed
- MindMed Reports Second Quarter 2023 Financial Results and Business Highlights - MindMed
- MindMed Announces Exclusive License Agreement With Catalent for Its Patented Zydis® Fast-Dissolve Technology for Use with MM-120 - MindMed
- View more press releases Close
通过电子邮件
